ELR-CXC chemokine antagonism and cisplatin co-treatment additively reduce H22 hepatoma tumor progression and ameliorate cisplatin-induced nephrotoxicity.
暂无分享,去创建一个
B. Wang | Qiang Li | J. Gordon | Jyawei Cheng | Fang Li | Jing Wei | Xiangyu Chen | Noman Khan | Jifei Chen